Guthrie Technology Tool Identifies COVID Patients for New Treatment
Sayre, Pa. – Guthrie announced this week it developed a way to provide swift delivery of a new treatment in select high-risk COVID patients using its electronic health record technology.Monoclonal antibodies, or mAbs, are made in a laboratory to fight certain infections, including SARS-CoV-2.... Read More.
